TWO SIGMA INVESTMENTS, LP

Position in MRKR — Marker Therapeutics, Inc.

CIK 1179392 NEW YORK, NY

Position in MRKR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$88,495

+$9,194 QoQ

Shares Held

60,201

-1.3% QoQ

Ownership

0.361%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 35 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. MRKR ranks #318 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$88,495	60,201	-1.3%	Shares	Sole	2026-08-14
2026-03-31	$79,301	61,001	-37.8%	Shares	Sole	2026-05-15
2025-12-31	$146,230	98,141	+168.6%	Shares	Sole	2026-02-17
2025-09-30	$32,520	36,540	+129.8%	Shares	Sole	2025-11-14
2022-12-31	$4,292	15,899	-70.5%	Shares	Sole	2023-02-14
2022-09-30	$19,962	53,953	-69.2%	Shares	Sole	2022-11-14
2022-06-30	$57,806	175,170	-31.5%	Shares	Sole	2022-08-15
2022-03-31	$112,516	255,719	-56.2%	Shares	Sole	2022-05-16
2021-12-31	$554,891	584,096	-34.1%	Shares	Sole	2022-02-14
2021-09-30	$1,499,045	887,009	-11.3%	Shares	Sole	2021-11-15
2021-06-30	$2,790,915	1,000,328	+816.1%	Shares	Sole	2021-08-16
2021-03-31	$244,608	109,200	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.